Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors

Abstract Development of cis -2,4,6-trisubstituted piperidine N -arylsulfonamides as γ-secretase inhibitors for the potential treatment of Alzheimer’s disease (AD) is reported.

[1]  I. Churcher,et al.  γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease , 2005 .

[2]  K. Nakayama,et al.  Synthesis of cerebroside B1b with antiulcerogenic activity I. Synthesis of ceramides with optically active α-hydroxypalmitic acids. , 1989 .

[3]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[4]  J. Normant,et al.  An Easy Synthesis of Aliphatic and Aromatic N-Sulfonyl Aldimines , 2000 .

[5]  R. J. Riley,et al.  Development of a Generalized, Quantitative Physicochemical Model of CYP3A4 Inhibition for Use in Early Drug Discovery , 2001, Pharmaceutical Research.

[6]  J. Edwards,et al.  A comparison of (chloromethyl)- and (iodomethyl)zinc cyclopropanation reagents , 1991 .

[7]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[8]  Maurice Dickins,et al.  Quantitative structure–activity relationships (QSARs) in CYP3A4 inhibitors: The importance of lipophilic character and hydrogen bonding , 2006, Journal of enzyme inhibition and medicinal chemistry.

[9]  A. Whiting,et al.  Asymmetric α-substitution versus aza Diels–Alder reaction of electron deficient N-sulfonyl imines , 2000 .

[10]  B. Snider,et al.  Alcohol inversion using cesium carboxylates and DMAP in toluene. , 2000, The Journal of organic chemistry.

[11]  Bu Hz,et al.  A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment. , 2006 .

[12]  D. Evans,et al.  Estimated prevalence of Alzheimer's disease in the United States. , 1990, The Milbank quarterly.

[13]  H. Josien.  Recent advances in the development of gamma-secretase inhibitors. , 2002, Current opinion in drug discovery & development.

[14]  Zhiqiang Zhao,et al.  Tetrahydroquinoline sulfonamides as γ-secretase inhibitors , 2007 .

[15]  W. Greenlee,et al.  2,6-Disubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors , 2007 .

[16]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[17]  W. Greenlee,et al.  Discovery of γ-secretase inhibitors efficacious in a transgenic animal model of Alzheimer’s disease , 2007 .